pharma and biotech
Mike Burgess, Robert Wasserman and Peter-Ulrich Rohr (Roche), Gary Gilliland
(Merck and Co), Nick Botwood (AstraZeneca), Shannon Morris (GlaxoSmithKline),
Samit Hirawat (Novartis), Antonella Isacchi and Arturo Galvani (Nerviano Medical
Sciences), Paul Billings and Martin Naley (Life Technologies),
Leo Bonilla (Agilent Technologies) and Ian Wilson (GE Healthcare).
academia and patient organizations
John Mendelsohn, Razelle Kurzrock and Donald Berry (UT-MD Anderson Cancer
Center), Samir Hanash (Fred Hutchinson Cancer Center), Leroy Hood (Institut
for Systems Biology Seattle), David Sidransky (Johns Hopkins University),
Stephen Friend (Sage Bionetworks), Keneth Anderson (Dana Farber Cancer
Institute),
Alexander Eggermont and Jean-Charles Soria (Institut Gustave Roussy), Janelle
Hail (National Breast Cancer Foundation), Julio E. Celis (Danish Cancer
Society),
Denis Lacombe (EORTC), Robert Kerbel (Sunnybrook Health Sciences Center),
Dominique Stoppa-Lyonnet (Institut Curie) and many others.